| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹40.58 | ₹43.95 | ₹30.17 | ₹27.61 |
| Other Income | ₹0.71 | ₹0.34 | ₹0.12 | ₹0.00 |
| Total Revenue | ₹41.29 | ₹44.28 | ₹30.28 | ₹27.62 |
| Total Expenses | ₹29.39 | ₹27.52 | ₹26.11 | ₹24.28 |
| Profit Before Tax | ₹11.90 | ₹16.76 | ₹4.17 | ₹3.33 |
| Tax | ₹1.17 | ₹4.26 | ₹1.06 | ₹0.76 |
| Profit After Tax | ₹10.73 | ₹12.50 | ₹3.11 | ₹2.57 |
| EPS - Basic | ₹6.63 | ₹8.01 | ₹2.00 | ₹1.65 |
| EPS - Diluted | ₹6.63 | ₹8.01 | ₹2.00 | ₹1.65 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹11.90 | ₹16.76 | ₹4.17 | ₹3.33 |
| Income before WC changes | ₹11.78 | ₹16.71 | ₹4.30 | ₹3.75 |
| Change in Assets | -₹4.96 | -₹9.84 | -₹1.28 | ₹3.97 |
| Change in Liabilities | ₹0.44 | -₹5.94 | ₹2.78 | -₹3.68 |
| Change in WC | -₹4.51 | -₹15.78 | ₹1.49 | ₹0.30 |
| Cash flow from Operations | ₹5.56 | -₹3.06 | ₹4.79 | ₹3.02 |
| Cash flow from Investing | -₹46.22 | -₹1.39 | -₹1.27 | -₹0.06 |
| Cash flow from Financing | ₹41.33 | -₹0.02 | -₹0.09 | ₹0.00 |
| Total Cash Flow | ₹0.67 | -₹4.46 | ₹3.43 | ₹2.96 |
| Cash (Start of the year) | ₹1.38 | ₹5.84 | ₹2.41 | -₹0.55 |
| Cash (End of the year) | ₹2.06 | ₹1.38 | ₹5.84 | ₹2.41 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹49.42 | ₹1.52 | ₹1.01 | ₹0.99 |
| Current Assets | ₹22.06 | ₹17.46 | ₹11.38 | ₹5.60 |
| Total Assets | ₹71.48 | ₹18.98 | ₹12.39 | ₹6.59 |
| Current Liabilities | ₹1.99 | ₹1.53 | ₹7.52 | ₹4.95 |
| Net Current Asset | ₹20.08 | ₹15.93 | ₹3.86 | ₹0.64 |
| Non-Current Liabilities | ₹0.28 | ₹0.29 | ₹0.27 | ₹0.15 |
| Equity Capital | ₹69.22 | ₹17.16 | ₹4.60 | ₹1.49 |
| Total Equity & Liabilities | ₹71.48 | ₹18.98 | ₹12.39 | ₹6.59 |
Amwill Health Care Limited is an India-based derma-cosmetic development company. The core focus of the Company is the development of problem-solving dermatological, cosmeceutical, and aesthetical products. The product portfolio of the Company is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific dermatological problems. It has a portfolio of products across various problem areas including hair care, skin care and lip care. Its product categories include anti acne, dry skin, anti-fungal, anti-histaminic, anti-perspirant, anti-biotics, skin lightening, special haircare, vitiligo, sunscreen, antioxidants, anti-scabies, and others. The products developed by the Company include Decomedo Gel, Pustulex Gel, Avertage Pro Cream, Histocross 180 Tabs, Depimed Ultra Cream 30 Gm, Ultra Kromaglo Effervescent Tablets, Depimed Tx Tablets, and Ultra Kromaglo Cream, among others.
Amwill Health Care Limited share price is ₹41.60 as on 02 Jul, 2026, 10:54 IST.
The Mutual Fund Shareholding in Amwill Health Care Limited was 0.00% at the end of Mar 2026.
The 52-week high and low of Amwill Health Care Limited share is ₹71.99 and ₹28.91 as of 02 Jul, 2026.
The market capitalisation of Amwill Health Care Limited is ₹83.21 Crores as on 02 Jul, 2026.
The stock symbol of Amwill Health Care Limited is 544353 on the BSE, and the ISIN is INE0U2L01017.
To buy Amwill Health Care Limited shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Amwill Health Care Limited shares closed yesterday at ₹41.60 on BSE
No, shares of Amwill Health Care Limited or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Amwill Health Care Limited shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.